Get tested for MSI-Hi .... Keytruda approved for MSI-Hi gene defects in prostate cancer or any other solid tumor cancer with overall 78%

[George71]

Some gene testing does not include MSI-Hi testing -- my first gene test did not include it even though it tested for 50 plus defects.

onclive.com/web-exclusives/...

curetoday.com/articles/keyt...

FDA clears Merck's Keytruda based on cancer genetics, not location

reuters.com/article/us-merc...

[AlanMeyer]

Great news! The percentage of cancer patients that will benefit is small (4%) and the percentage with prostate cancer is even smaller, but the absolute numbers of people are large - 15-20 thousand patients per year in the U.S. That's a lot of people who will potentially experience significant remissions. The numbers quoted above are from the Reuters article.

Cancer treatment is still very much a one step at a time process. Find something for one slice of patients, then another, then another, then another, and pretty soon we're talking real progress.

Alan

[dadeb in reply to AlanMeyer]

Treatments seem like a big crap shoot. Luck of the random draw. But luckily, there are more and more options every day. Fascinating reads on Keytruda.

[j-o-h-n]

As per my previous posts... I'm being treated for a lung melanoma with Keytruda... and it's working... (but not for my Pca)

Good Luck and Good Health.

j-o-h-n Monday 05/07/2018 2:00 PM EDT

[dadeb in reply to j-o-h-n]

That’s great news on the melanoma. Keep on the keepin on! Hope the psa starts falling too.